154 related articles for article (PubMed ID: 7528602)
1. Desmopressin for risperidone-induced enuresis.
Bennett JA; Keck PE; Wallhausser LJ
Ann Clin Psychiatry; 1994 Jun; 6(2):139-40. PubMed ID: 7528602
[No Abstract] [Full Text] [Related]
2. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
4. Risperidone: clinical safety and efficacy in schizophrenia.
Borison RL; Pathiraja AP; Diamond BI; Meibach RC
Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
[TBL] [Abstract][Full Text] [Related]
5. Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group.
Müller-Spahn F
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():90A-91A. PubMed ID: 1379882
[No Abstract] [Full Text] [Related]
6. Risperidone: a novel antipsychotic medication.
Land W; Salzman C
Hosp Community Psychiatry; 1994 May; 45(5):434-5. PubMed ID: 7519166
[No Abstract] [Full Text] [Related]
7. Risperidone in adolescents.
Cozza SJ; Edison DL
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
[No Abstract] [Full Text] [Related]
8. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
9. Risperidone: clinical issues in treatment.
Littrell K; Schultz RE
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):47-9. PubMed ID: 7519677
[No Abstract] [Full Text] [Related]
10. Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
Wilms G; Van Ongeval C; Baert AL; Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):306-12. PubMed ID: 1375802
[TBL] [Abstract][Full Text] [Related]
11. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Dickson R; Williams R; Dalby JT
Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
[No Abstract] [Full Text] [Related]
12. Risperidone: clinical development: north American results.
Marder SR
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():92A-93A. PubMed ID: 1379883
[TBL] [Abstract][Full Text] [Related]
13. Clinical review of risperidone.
Chouinard G; Arnott W
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
[TBL] [Abstract][Full Text] [Related]
14. A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
Möller HJ; Müller H; Borison RL; Schooler NR; Chouinard G
Eur Arch Psychiatry Clin Neurosci; 1995; 245(1):45-9. PubMed ID: 7540426
[TBL] [Abstract][Full Text] [Related]
15. Risperidone in the treatment of schizophrenia.
Marder SR; Meibach RC
Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
[TBL] [Abstract][Full Text] [Related]
16. Behavioral stimulation associated with risperidone initiation.
Byerly MJ; Greer RA; Evans DL
Am J Psychiatry; 1995 Jul; 152(7):1096-7. PubMed ID: 7540799
[No Abstract] [Full Text] [Related]
17. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.
Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):295-305. PubMed ID: 1375801
[TBL] [Abstract][Full Text] [Related]
18. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
19. Risperidone for schizophrenia.
Edwards JG
BMJ; 1994 May; 308(6940):1311-2. PubMed ID: 7517246
[No Abstract] [Full Text] [Related]
20. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
